Tubal Ligation Reversal in India
Get Tubal Ligation Reversal at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Tubal Ligation Reversal in UAE
Tubal Ligation Reversal at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Tubal ligation reversal (tubal reanastomosis) is a microsurgical procedure that reconnects the fallopian tubes after a previous sterilization, restoring natural fertility with pregnancy rates ranging from 40% to 85% depending on patient age, tube length remaining, and the original ligation technique. India and the UAE have emerged as premier destinations for this procedure, offering world-class microsurgical and robotic-assisted expertise at a fraction of Western costs, with GAF Healthcare coordinating every step of the international patient journey — from diagnostic evaluation to post-operative follow-up.
Hospital Stay: 1–2 days (laparoscopic/robotic); 2–3 days (open microsurgery) • Total Stay in Country (Fit-to-Fly): 2–3 weeks (short-haul); 3–4 weeks (long-haul intercontinental flights) • Success Rate: 40%–85% cumulative pregnancy rate within 24 months (age and tubal length dependent)
What Is It?
Tubal ligation reversal, formally termed tubal reanastomosis or microsurgical tubal reconstruction, restores patency to the fallopian tubes that were previously occluded, cut, or removed in segments during sterilization. The procedure is physiologically significant because the fallopian tube is not merely a passive conduit — its ciliated epithelium, peristaltic musculature, and secretory environment are critical for oocyte capture, sperm transport, fertilization, and early embryo development. When tubal continuity is surgically restored, this entire functional micro-environment can be re-established, enabling natural conception without assisted reproductive technology.
The original sterilization method is the single greatest determinant of reversal feasibility and success. Methods such as Filshie clips or Falope rings cause minimal tubal damage and are associated with the highest reversal success rates (up to 80–85%), as they preserve maximum tubal length. In contrast, Pomeroy ligation, electrocautery fulguration, and salpingectomy (complete tube removal) result in greater tissue loss, leaving shorter or absent tubal segments that significantly reduce or eliminate reversal candidacy. The critical anatomical parameter is the remaining tubal length: a minimum of 4 cm of healthy, patent tube on each side is generally required to achieve a functional anastomosis.
The current standard of care combines high-resolution preoperative imaging (hysterosalpingography or saline infusion sonography) with microsurgical technique under optical magnification — either surgical loupes (×4–×6) or robotic assistance (da Vinci Surgical System) — to achieve a tension-free, well-vascularized, lumen-to-lumen anastomosis using fine absorbable sutures (6-0 or 7-0 polyglactin). Leading centers in India and the UAE routinely incorporate robotic-assisted laparoscopic tubal reanastomosis, which offers three-dimensional magnification, tremor filtration, and superior instrument articulation compared to conventional laparoscopy, translating into superior anastomotic precision.
Candidates
• IDEAL CANDIDATES:
• Women under 37 years of age (highest pregnancy rates; acceptable candidacy up to age 42 with thorough counseling)
• Minimum 4 cm of healthy fallopian tube remaining bilaterally, confirmed on hysterosalpingography (HSG) or diagnostic laparoscopy
• Original sterilization by clip (Filshie/Hulka), ring (Falope), or Pomeroy technique (not fulguration to the cornua or salpingectomy)
• Normal ovarian reserve: Anti-Müllerian Hormone (AMH) ≥ 1.0 ng/mL, Antral Follicle Count (AFC) ≥ 7, Day-3 FSH < 10 mIU/mL
• Normal uterine cavity confirmed by saline infusion sonography (SIS) or hysteroscopy — absence of fibroids, polyps, or Asherman's syndrome
• Partner with confirmed normal semen analysis (WHO 2021 reference criteria): concentration ≥ 16 million/mL, motility ≥ 42%, morphology ≥ 4% normal forms
• BMI < 35 kg/m² (obesity increases anesthetic risk and reduces surgical visualization)
• No active pelvic inflammatory disease (PID), endometriosis stage III/IV, or extensive pelvic adhesions
• REQUIRED PREOPERATIVE DIAGNOSTICS:
• Hysterosalpingography (HSG) — to map the proximal tubal stump length and assess uterine cavity
• Transvaginal ultrasound with antral follicle count (AFC)
• Hormonal panel: AMH, Day-3 FSH, LH, Estradiol, Prolactin, TSH
• Complete blood count, coagulation profile (PT/INR/aPTT), renal and hepatic function tests
• Infectious disease screening: HIV, Hepatitis B surface antigen, Hepatitis C antibody, VDRL/RPR
• Pap smear within last 3 years (or repeat if overdue)
• Partner semen analysis
• Diagnostic laparoscopy (in select cases where HSG is inconclusive regarding distal tube status)
• CONTRAINDICATIONS (ABSOLUTE):
• Prior bilateral salpingectomy (no tubal remnant available for anastomosis)
• Remaining tubal length < 2 cm bilaterally after anticipated resection of damaged segments
• Severely compromised ovarian reserve (AMH < 0.5 ng/mL, FSH > 15 mIU/mL) where IVF offers superior outcomes
• Active malignancy of the reproductive tract
• Uncontrolled medical comorbidities precluding general anesthesia
• Partner with azoospermia or severe oligo-asthenoteratozoospermia unresponsive to treatment
• RELATIVE CONTRAINDICATIONS (REQUIRE INDIVIDUALIZED COUNSELING):
• Age ≥ 40 years (pregnancy rates fall to 30–40%; IVF comparison counseling mandatory)
• Electrocautery sterilization with extensive cornual involvement
• Prior ectopic pregnancy history (elevated risk of repeat ectopic post-reversal)
• Endometriosis stage I/II (managed surgically at time of reversal if feasible)
Procedure
SURGICAL APPROACHES TO TUBAL REANASTOMOSIS:
1. ROBOTIC-ASSISTED LAPAROSCOPIC TUBAL REANASTOMOSIS (RALTR) — MOST ADVANCED:
Using the da Vinci Xi or da Vinci SP Surgical System, this approach provides 10× to 15× three-dimensional magnification, 7 degrees of freedom with EndoWrist instrumentation, and active tremor filtration. The surgeon performs the anastomosis with 6-0 or 7-0 polyglactin (Vicryl) sutures in a two-layer technique (muscularis and serosa separately) under superior optical clarity. RALTR is now the preferred approach at centers of excellence in both India and the UAE. It carries the advantages of minimally invasive surgery (smaller incisions, less blood loss, faster recovery) combined with microsurgical precision previously achievable only via laparotomy. Operating time: 90–150 minutes.
2. CONVENTIONAL LAPAROSCOPIC TUBAL REANASTOMOSIS:
Performed with standard laparoscopic instruments and surgical loupes or camera magnification. Technically demanding due to the two-dimensional view and reduced instrument dexterity compared to robotic assistance. Suitable for experienced minimally invasive gynecological surgeons. Shorter operative time in experienced hands (60–120 minutes). Increasingly being replaced by RALTR at high-volume centers.
3. OPEN MICROSURGICAL TUBAL REANASTOMOSIS (MINI-LAPAROTOMY):
Historically the gold standard, performed through a Pfannenstiel incision with the operating microscope (×8–×25 magnification) and microsurgical instruments (jewelers' forceps, micro-scissors). A two-layer anastomosis is created — mucosal layer with 7-0 nylon or polyglactin, followed by musculoserosal layer with 6-0 polyglactin. Despite higher invasiveness, this approach remains relevant when robotic equipment is unavailable or when extensive peritubal adhesiolysis is required simultaneously. Published pregnancy rates are comparable to RALTR when performed by expert microsurgeons.
4. ANASTOMOTIC TECHNIQUES BY SEGMENT:
• Isthmo-isthmic anastomosis: Best outcomes (both segments are narrow-caliber, similar diameter). Pregnancy rates 75–85%.
• Isthmo-ampullary anastomosis: Good outcomes; diameter mismatch is managed by spatulating the narrower segment.
• Ampullo-ampullary anastomosis: Acceptable outcomes when adequate length remains.
• Cornual (interstitial) implantation: Reserved for cases with proximal occlusion at the uterine cornua; technically complex, lower success rates.
5. ADJUNCT PROCEDURES PERFORMED SIMULTANEOUSLY:
• Adhesiolysis for pelvic adhesions
• Laparoscopic treatment of incidentally found endometriosis implants
• Ovarian cystectomy (if a benign cyst is identified)
• Chromopertubation: Blue dye instilled transcervically at the conclusion of surgery to confirm tubal patency before closing
6. TUBAL REVERSAL vs. IN VITRO FERTILIZATION (IVF) — DECISION FRAMEWORK:
For women under 37 with good ovarian reserve and favorable anatomy, tubal reversal offers cumulative pregnancy rates that equal or exceed a single IVF cycle at significantly lower total cost, with the added benefit of multiple natural conception attempts. For women over 40, those with poor ovarian reserve, or those with salpingectomy, IVF is the evidence-based recommendation. GAF Healthcare's fertility specialists provide individualized decision consultations comparing both pathways.
Cost of Tubal Ligation Reversal: India vs. UAE
The cost of tubal ligation reversal varies significantly depending on the destination, hospital tier, surgical approach (laparoscopic, robotic, or open), and whether ancillary procedures such as adhesiolysis or diagnostic laparoscopy are required. India offers the most cost-competitive pricing globally for high-quality microsurgical care, typically 50–65% lower than equivalent procedures in the UAE and 70–80% lower than the United States or United Kingdom, without compromising on surgical expertise or accreditation standards. The UAE (Dubai and Abu Dhabi) represents a premium medical tourism destination offering luxury hospital environments, seamless international connectivity, and JCI/DHA-accredited care at pricing still substantially below Western Europe or North America. Both destinations accessed through GAF Healthcare include comprehensive coordination, pre-operative diagnostics management, and post-operative support.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $1,800 – $3,500 | ~58% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $4,500 – $8,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PHASE 1 — REMOTE PRE-CONSULTATION (4–6 weeks before travel):
• Submit medical records to GAF Healthcare: operative report from original tubal ligation, any prior pelvic surgery reports, HSG films or reports, recent hormonal panel results, and partner semen analysis
• GAF Healthcare assigns a dedicated Patient Coordinator who facilitates a video consultation with the treating gynecologist/reproductive surgeon within 48–72 hours of document submission
• Surgeon reviews tubal ligation technique, estimates remaining tubal length, and provides a candidacy assessment and success rate estimate specific to the patient
• Multidisciplinary review includes a reproductive endocrinologist if ovarian reserve parameters require discussion
• If HSG has not been performed, it is scheduled locally or on arrival depending on availability
PHASE 2 — ARRIVAL AND PRE-OPERATIVE WORKUP (Days 1–2 in country):
• Airport pickup by GAF Healthcare ground team; transfer to partner hospital or serviced accommodation
• Day 1: Hospital admission for pre-operative assessment — blood tests (if not done remotely), anesthesia consultation, pelvic ultrasound with AFC, and final surgical planning conference with the operating surgeon
• Day 2 (morning of surgery): NPO (nil per os) from midnight; pre-operative medications administered; written informed consent obtained with the assistance of a GAF Healthcare medical interpreter if required
• Anesthesia: General endotracheal anesthesia with multimodal analgesia (opioid-sparing protocol using dexamethasone, ketorolac, and ondansetron)
PHASE 3 — THE SURGICAL PROCEDURE (Day 2 or 3, 2–3 hours including setup):
• Laparoscopic or robotic port placement (typically 4 ports for robotic; 3 ports for laparoscopic)
• Systematic pelvic survey to assess adhesions, endometriosis, ovarian status, and tubal stumps
• Identification and excision of damaged/occluded tubal segments back to healthy, bleeding tissue
• Microsurgical or robotic two-layer anastomosis performed under magnification with fine absorbable sutures
• Chromopertubation with methylene blue or indigo carmine to confirm patency bilaterally
• Port closure and skin closure; procedure complete in 90–150 minutes for robotic/laparoscopic
PHASE 4 — IMMEDIATE POST-OPERATIVE RECOVERY (Day 2–4, in hospital):
• Recovery room observation for 2–4 hours post-anesthesia
• Ambulation encouraged on the evening of surgery (laparoscopic/robotic cases)
• Oral analgesia: acetaminophen (paracetamol) + ibuprofen scheduled, with tramadol or low-dose opioids available PRN
• Antibiotic prophylaxis: single-dose cefazolin intraoperatively; extended oral course if adhesiolysis was extensive
• Anti-thrombotic prophylaxis: LMWH (enoxaparin) for high-risk patients; compression stockings for all patients
• Discharge criteria: tolerating oral diet, pain controlled on oral medications, no fever, no signs of surgical site complications
• Laparoscopic/robotic patients: discharged Day 1–2 post-op; open (mini-laparotomy) patients: discharged Day 2–3 post-op
PHASE 5 — IN-COUNTRY RECOVERY PERIOD (Week 1–3 after surgery):
• Days 3–7: Rest at accommodation; mild walking encouraged; avoid lifting > 5 kg, strenuous activity, and sexual intercourse
• Day 7: Post-operative wound check and suture inspection (absorbable sutures do not require removal); surgical and nursing review
• Week 2: Gradual return to light activity; most patients report resolution of post-operative bloating and shoulder tip pain (from residual CO₂) by Day 4–5
• Week 2–3: Final pre-departure consultation with the surgeon; confirmation of wound healing and absence of complications; written discharge summary, surgical report, and post-operative instructions provided
PHASE 6 — FIT-TO-FLY CLEARANCE AND DEPARTURE:
• Laparoscopic/robotic cases: Cleared for short-haul flights (< 4 hours) at 2 weeks; intercontinental flights (> 6 hours) at 3 weeks with compression stockings and in-flight ambulation instructions
• Open microsurgery cases: Cleared for short-haul at 3 weeks; intercontinental at 4 weeks
• DVT prevention: All patients prescribed LMWH or oral anticoagulant for flights > 4 hours post-gynecological surgery
PHASE 7 — POST-DEPARTURE FOLLOW-UP AND TTC GUIDANCE:
• Avoid attempting to conceive for the first menstrual cycle following surgery to allow tubal healing
• Begin trying to conceive (TTC) from the second post-operative menstrual cycle
• Monthly pregnancy tests from Month 2 onward; early ultrasound at 6–7 weeks gestation to confirm intrauterine location (ectopic pregnancy risk is elevated at 5–10% post-reversal vs. 1–2% in the general population)
• If no natural conception after 12 months of TTC (or 6 months for women > 37), transition to IVF is recommended
• GAF Healthcare provides telemedicine follow-up at 6 weeks, 3 months, 6 months, and 12 months post-operatively
Risks & Considerations
Tubal ligation reversal is a well-tolerated procedure with an excellent safety profile when performed by an experienced reproductive or gynecological microsurgeon at an accredited center, but patients must be comprehensively counseled on the following specific risks:
SURGICAL AND ANESTHETIC RISKS: General anesthesia carries standard risks including adverse drug reactions, aspiration, and rare cardiovascular events. Intraoperative risks include inadvertent injury to adjacent structures (bowel, bladder, ureter, iliac vessels), though these are uncommon (< 1%) in elective laparoscopic gynecological surgery at high-volume centers. Hemorrhage requiring conversion from laparoscopic to open surgery occurs in < 2% of cases.
Top Hospitals for Tubal Ligation Reversal
The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.
Manipal Hospitals Dwarka
New Delhi, India
Burjeel Hospital for Advanced Surgery Dubai
Dubai, UAE
Kings College Hospital Dubai
Dubai, UAE
Aster Hospital Dubai
Dubai, UAE
Top Doctors for Tubal Ligation Reversal
Internationally trained specialists in Gynecology. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. Tarang Preet Kaur
MBBS, MS, MRCOG, MCh, Fellowship in Urogynaecology, Fellowship in Cosmetic Gynaecology
Urogynaecologist
Max Super Speciality Hospital, Saket, New Delhi, India
11+ Yearsof experience
Dr. Tarang Preet Kaur is a Consultant in Urogynaecology with over 11 years of clinical experience, currently practicing at Max Super Speciality Hospital, Saket in New Delhi. She holds an MCh in Urogynaecology from Edge Hill University, United Kingdom (2024), the MRCOG from the Royal College of Obstetricians & Gynaecologists, and an MS in Obstetrics & Gynaecology from Maulana Azad Medical College, Delhi. Her dual qualification across India and the UK… Read more
Dr. Amrinder Kaur Bajaj
MBBS, MD — Obstetrics & Gynaecology (Gold Medalist), Senior Residency — Obstetrics & Gynaecology, FRSH — Fellow of the Royal Society of Health, FIAMS — Fellow of the Indian Association of Medical Specialists
Obstetrician & Gynaecologist
Fortis Hospital, Gurgaon, Gurgaon, India
42+ Yearsof experience
Dr. Amrinder Kaur Bajaj is one of Delhi-NCR's most experienced gynaecologists, with over four decades spent caring for women at every stage of life. She currently practises as a Consultant in Obstetrics & Gynaecology at Fortis Hospital, Gurgaon, where she brings together deep clinical knowledge and a quietly reassuring bedside manner that patients — and their families — find genuinely comforting. Her academic journey set a high bar early on. She completed… Read more
Dr. Anuradha Khurana
MBBS, DGO (Diploma in Obstetrics & Gynaecology), PG in High Risk Pregnancy and Infertility
Gynecologist & Obstetrics Specialist
Artemis Hospital, New Delhi, India
20+ Yearsof experience
Dr. Anuradha Khurana is a Senior Consultant in Obstetrics and Gynecology at Artemis Hospital, Delhi, with over two decades of hands-on experience in women's health. She is particularly well regarded for her work in high-risk pregnancy management, uterine conditions like fibroids and endometriosis, and complex gynecological surgeries. Patients and families consistently describe her as someone who takes the time to truly listen — and to explain things in a… Read more
Dr. Aswari Kesari Kapoor
MBBS, DGO (Diploma in Gynaecology & Obstetrics), CPS (College of Physicians and Surgeons), DNB (Diplomate of National Board) — Obstetrics & Gynaecology
Obstetrician & Gynecologist
Indraprastha Apollo Hospital, New Delhi, India
23+ Yearsof experience
Dr. Aswari Kesari Kapoor is a seasoned Obstetrician and Gynecologist with over 23 years of hands-on clinical experience. She practices at Indraprastha Apollo Hospital in New Delhi — one of India's most respected multi-specialty institutions. Over the course of her career, she has built a strong reputation for managing complex gynecological conditions alongside high-risk pregnancies, all with a calm and reassuring bedside manner that patients consistently… Read more
Dr. Bindhu K S
MBBS, DNB (Obstetrics & Gynecology), Fellowship in Minimal Access Surgery, FICOG (Fellowship of the Indian College of Obstetricians and Gynaecologists), Certificate in Gynecologic and Obstetric Sonography, Certificate in Appreciation of Well Being in Fetal Heart Disease
Obstetrician & Gynecologist
Apollo Hospitals, Navi Mumbai, Mumbai, India
23+ Yearsof experience
Dr. Bindhu K S is a seasoned Obstetrician and Gynecologist based in Mumbai, currently practicing at Apollo Hospitals, Navi Mumbai. With over two decades of clinical experience, she brings together expertise in both obstetrics and advanced minimally invasive gynecologic surgery. Whether a patient comes with a complex fibroid, troublesome endometriosis, or a high-risk pregnancy, Dr. Bindhu approaches each situation with careful thought and genuine care. Her… Read more
Patient Success Story
Frequently Asked Questions — Tubal Ligation Reversal
The total cost of tubal ligation reversal — including surgeon fees, hospital stay, operating theater charges, anesthesia, standard medications, and post-operative consultations — ranges from approximately USD 1,800 to USD 3,500 in India and USD 4,500 to USD 8,000 in the UAE (Dubai/Abu Dhabi). India is typically 50–65% less expensive than the UAE for equivalent surgical expertise and accreditation standards. The cost variation within each country reflects the choice of surgical approach (robotic-assisted procedures carry a premium of USD 500–1,000 over conventional laparoscopy), hospital tier (corporate JCI/NABH-accredited centers vs. government tertiary hospitals in India; DHA-licensed private hospitals in the UAE), and whether additional intraoperative procedures such as adhesiolysis or endometriosis treatment are required. Compared to the United States (where tubal reversal typically costs USD 8,000–20,000 and is rarely covered by insurance) or the United Kingdom (£7,000–£12,000 privately), both India and the UAE represent substantial cost savings. GAF Healthcare provides a fully itemized cost estimate after reviewing each patient's medical records and confirms the final package price before any commitment is made.
The minimum recommended in-country stay before an international flight depends on the surgical approach and the duration of the intended flight. For patients undergoing robotic-assisted or conventional laparoscopic tubal reanastomosis (the most common approach), fit-to-fly clearance for short-haul flights (under 4 hours) is typically granted at 2 weeks post-surgery, and for intercontinental long-haul flights (over 6 hours) at 3 weeks post-surgery. For patients who undergo open microsurgical reanastomosis via mini-laparotomy, these timelines extend to 3 weeks (short-haul) and 4 weeks (long-haul). These recommendations exist because all major gynecological surgeries — particularly those involving general anesthesia and intraperitoneal access — significantly elevate the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prolonged immobility in an aircraft cabin compounds this risk. GAF Healthcare's treating surgeons issue a formal fit-to-fly certificate at the pre-departure consultation. All patients traveling on flights longer than 4 hours within 4 weeks of surgery are prescribed pharmacological thromboprophylaxis (LMWH injection or oral anticoagulant) and compression stockings, and are instructed on in-flight calf exercises and ambulation protocols.
The cumulative pregnancy rate following tubal ligation reversal ranges from 40% to 85% within 24 months of the procedure, making it one of the most effective fertility-restoring surgeries when patient selection is appropriate. The success rate is not uniform and is determined by a precise combination of biological and anatomical factors. The most predictive factors are: (1) Patient age — women under 35 achieve pregnancy rates of 70–85%; rates fall to 50–65% at age 35–37, 30–45% at age 38–40, and 20–30% at age 40–42; (2) Remaining tubal length — a minimum of 4 cm of healthy tube is required; tubes of 6 cm or more are associated with the highest success rates; (3) Original sterilization method — clip and ring sterilizations cause minimal damage and are associated with the best reversal outcomes (up to 85% pregnancy rate); Pomeroy ligation and electrocautery fulguration result in greater tissue loss and lower success rates (50–70%); (4) Ovarian reserve — measured by AMH level and antral follicle count; women with diminished ovarian reserve (AMH < 1.0 ng/mL) have reduced conception rates regardless of tubal patency; (5) Partner semen quality — a normal semen analysis is a prerequisite for favorable outcomes. It is important to understand that the quoted success rate reflects pregnancy achievement, not necessarily live birth rate, which is approximately 5–10% lower due to miscarriage risk. Additionally, there is a 5–10% risk of ectopic (tubal) pregnancy following reversal, which is why early ultrasound confirmation of intrauterine pregnancy is mandatory. GAF Healthcare's surgical team provides each patient with an individualized success rate estimate based on their specific diagnostic data before committing to surgery.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides an end-to-end medical tourism coordination service that eliminates the administrative burden of international medical travel, ensuring patients can focus entirely on their health and recovery.
VISA AND ENTRY DOCUMENTATION — INDIA: GAF Healthcare facilitates the Indian e-Medical Visa (e-MV) application, which permits stays of up to 60 days (extendable) specifically for medical treatment and is available to nationals of 156 eligible countries. Our team prepares and reviews the application package — including the official hospital invitation letter from the treating institution, diagnostic and appointment confirmations, and the online MHA portal submission — typically achieving approval within 3–5 business days. The e-Medical Visa also allows one attendant (companion) on a concurrent e-Medical Attendant Visa (e-MAtv). Our team monitors approval status and provides pre-travel documentation checklists.
VISA AND ENTRY DOCUMENTATION — UAE (DUBAI / ABU DHABI): The UAE operates one of the world's most accessible entry frameworks for medical tourists. Nationals of GCC countries, EU member states, the United Kingdom, the United States, Canada, Australia, and approximately 50 additional countries are granted visa-free entry or visa-on-arrival for 30–90 days. For nationalities requiring a pre-arranged visa, GAF Healthcare coordinates the UAE medical treatment visa application through its Dubai and Abu Dhabi hospital partners. Dubai Health Authority (DHA) and Department of Health Abu Dhabi (DoH) licensed facilities issue the required medical treatment confirmation letters.
AIRPORT AND GROUND TRANSFERS: Dedicated meet-and-greet service at the international arrival terminals of all major partner airports (Delhi IGI, Mumbai CSIA, Chennai MAA, Dubai DXB, Abu Dhabi AUH). Transfers are in clean, air-conditioned vehicles with a GAF Healthcare ground team member present for direct communication. Wheelchair and ambulatory assistance is arranged in advance for patients with mobility limitations.
MEDICAL INTERPRETATION AND TRANSLATION: GAF Healthcare maintains a roster of qualified medical interpreters fluent in Arabic, Russian, French, Swahili, Bangla, and other major international patient languages. Interpreters accompany patients during surgical consultations, pre-operative consent discussions, and post-operative discharge briefings to ensure clinical information is conveyed accurately and that patients can ask questions in their native language without ambiguity.
ACCOMMODATION FOR PATIENTS AND ATTENDANTS: GAF Healthcare partners with serviced apartments, patient guest houses, and hotels within 5–15 minutes of each partner hospital, providing furnished accommodation suitable for the 2–3 week in-country recovery stay. Options are available across budget tiers (standard to premium). Attendant accommodation is arranged concurrently, ensuring the patient's companion is housed in the same building or complex. Meal delivery, housekeeping, and 24-hour emergency contact with the GAF Healthcare Patient Coordinator are standard inclusions.
CONTINUITY OF CARE AND REMOTE FOLLOW-UP: Following departure, GAF Healthcare remains the communication bridge between the patient and the treating surgical team. All operative reports, histopathology results, discharge summaries, and post-operative prescriptions are digitized and shared via a secure patient portal. Telemedicine follow-up appointments are scheduled at 6 weeks, 3 months, and 6 months post-surgery, enabling the treating surgeon to review wound healing, discuss pregnancy attempt timelines, and order any remote investigations (such as post-operative HSG) through GAF Healthcare's network of partner laboratories in the patient's home country.